Zynex Announces New In-Network Provider Status with Humana

Zynex (ZYXIQ) announced a new in-network provider agreement with Humana (HUM), effective February 1, 2026.

Rhea-AI Summary

Zynex (ZYXIQ) announced a new in-network provider agreement with Humana (HUM), effective February 1, 2026.

The agreement brings Zynex electrotherapy products, including NexWave™, into Humana Medicare-PPO, POS, PFFS, HMO and multiple state Medicaid plans, expanding patient access nationwide; terms were not disclosed.

Argus Feb 4 session

-0.49% close to close Open Argus

Details

News Market Reaction – HUM

On Feb 4, the day this news came out, HUM closed 0.49% below the previous close.

Data tracked by StockTitan Argus for the Feb 4 session.

Market Context

This announcement highlights Humana’s addition of Zynex as an in‑network provider across multiple pl...

Analysis

This announcement highlights Humana’s addition of Zynex as an in‑network provider across multiple plan types, including Medicare and various Medicaid offerings, effective February 1, 2026. It broadens member access to non‑invasive electrotherapy for pain management within an established national insurer serving nearly 20 million people. Investors may watch for utilization data, member adoption, and any subsequent expansions of similar device‑based partnerships to gauge the long‑term strategic impact.

Key Figures

Humana members served: nearly 20 million people Effective date: February 1, 2026

Humana members served

nearly 20 million people

Humana membership across all fifty states

Effective date

February 1, 2026

Start of Zynex in-network provider agreement with Humana

Historical Context

5 past events · Latest: Jan 26

5 events

1. Jan 26

   Scholarship initiative

   24h Move

   -1.1%

   $3M scholarship fund to expand physician workforce in Louisiana.

2. Jan 13

   Oncology partnership

   24h Move

   -0.9%

   Partnership with Atlas Oncology to expand coordinated cancer care.

3. Jan 12

   Pharmacy program

   24h Move

   -0.1%

   CenterWell Pharmacy to dispense obesity drugs in employer program.

4. Jan 09

   Earnings scheduling

   24h Move

   -0.3%

   Announcement of Q4 2025 results release and earnings call timing.

5. Dec 17

   Nursing mentorship

   24h Move

   +0.8%

   Partnership to fund Mentoring for Success program for nursing students.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

medicare advantage, medicaid, hmo, ppo, +3 more

7 terms

medicare advantage regulatory

"second-largest provider of Medicare Advantage plans, Humana continues"

Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.

medicaid regulatory

"Kentucky Medicaid HMO, Illinois Medicaid Plans and Integrated DSNP Plans"

Medicaid is a government-funded health insurance program that provides medical coverage to low-income individuals, families, elderly people and people with disabilities, administered jointly by the federal government and state governments in the United States. For investors, Medicaid matters because changes in eligibility, funding, or payment rules can alter patient volume and the prices hospitals, nursing homes, insurers and medical suppliers receive—similar to how a large customer or contract can shift a company’s revenue outlook.

hmo technical

"Medicare-PPO Plans, POS Plans, Network PFFS Plans, and HMO Plans"

HMO stands for Health Maintenance Organization, a type of managed health insurance plan that gives members access to a network of doctors and hospitals for a fixed premium and generally requires using in-network providers or referrals for specialists. Investors watch HMO performance because membership levels, cost controls and care network agreements directly affect revenue, profit margins and regulatory exposure—think of it as a subscription service that must balance member satisfaction with cost containment.

ppo technical

"Medicare-PPO Plans, POS Plans, Network PFFS Plans, and HMO Plans"

A PPO, or preferred provider organization, is a type of health insurance plan that gives members a network of doctors and hospitals who agree to lower fees, while still allowing patients to see providers outside the network at higher cost. Investors care because PPOs influence how medical services are paid for and used, affecting revenue and margins for insurers, hospitals, drug makers and companies that serve employer health plans—think of it as a merchant discount program that shapes who customers choose and what they pay.

pffs technical

"POS Plans, Network PFFS Plans, and HMO Plans, as well as Kentucky"

Preferred shares (often written informally as “pffs”) are a class of company stock that sits between bonds and common shares: they usually pay a fixed dividend like a bond but don’t carry the same voting rights as regular shareholders. For investors, they matter because they can provide steadier income and higher claim on assets during a bankruptcy, acting like a middle-ground option for income-focused portfolios that want more stability than common stock but more upside than plain debt.

dsnp regulatory

"Illinois Medicaid Plans and Integrated DSNP Plans, Indiana PathWays"

DSNP stands for Dual Eligible Special Needs Plan, a type of Medicare Advantage plan designed specifically for people who qualify for both Medicare and Medicaid. Think of it as a tailored insurance package that coordinates two government programs to simplify care and lower out-of-pocket costs. Investors watch DSNPs because they can drive steady enrollment and government-funded revenue streams for health insurers, while also carrying regulatory and cost-management risks that affect profitability.

electrotherapy medical

"our advanced electrotherapy products, including our NexWave™ device"

Electrotherapy uses controlled electrical currents delivered by medical devices to treat pain, stimulate muscles, or promote healing — like a targeted electrical nudge that prompts nerves or tissue to respond. It matters to investors because device design, clinical evidence, regulatory approvals and insurance coverage determine how widely a therapy is adopted and whether a company can generate durable sales and recurring revenue, so changes in those areas can quickly alter a maker's market prospects.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ENGLEWOOD, Colo., Feb. 4, 2026 /PRNewswire/ -- Zynex, Inc. (ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the first time entered into a provider agreement with Humana Inc. (NYSE: HUM), effective February 1, 2026.

"Our non-invasive medical technology improves quality of life for patients with debilitating pain and is a safe and effective alternative for pain management," said Kurt Hudson, Executive Vice President of Marketing. "We are pleased to offer our advanced electrotherapy products, including our NexWave™ device, to in-network Humana members."

Consistently ranked as one of the largest health insurance companies in the United States, and the second-largest provider of Medicare Advantage plans, Humana continues to be a leader among insurers, serving nearly 20 million people across all fifty states. Humana offers products and services through traditional and consumer choice health plans to employer groups, government-sponsored plans, and individuals, as well as primary and workplace care through its medical centers and worksite medical facilities.

"Partnering with a health insurance leader like Humana will expand patient access," added Steven Dyson, Chief Executive Officer. "We thank Humana for trusting our team to serve their members under this agreement and demonstrate how Zynex can provide the highest technology and service standards in the electrotherapy industry with transparency, integrity, and compliance."

Zynex is now participating in health benefits plans offered or administered by Humana, including Medicare-PPO Plans, POS Plans, Network PFFS Plans, and HMO Plans, as well as Kentucky Medicaid HMO, Illinois Medicaid Plans and Integrated DSNP Plans, Indiana PathWays for Aging, Ohio Medicaid Plans, Oklahoma Medicaid, South Carolina Medicaid Plans, Virginia Medicaid Plans, and Michigan Medicaid Plans.

Terms of the agreement were not disclosed.

About Zynex, Inc.
Zynex, founded in 1996, is a pain management device manufacturer and distributor. For additional information, visit: www.zynex.com.

Investor Relations Contact:
Vikram Bajaj, CFO 
E-mail: ir@zynex.com

Media Contact:
Britt Logan DiGiulio
E-mail: media@zynex.com

View original content:https://www.prnewswire.com/news-releases/zynex-announces-new-in-network-provider-status-with-humana-302679009.html

SOURCE Zynex, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Zynex announce about its provider status with Humana (HUM) on February 4, 2026?

Zynex entered an in-network provider agreement with Humana effective February 1, 2026, for the first time. According to the company, the deal places Zynex electrotherapy products, including NexWave™, into Humana Medicare-PPO, POS, PFFS, HMO and multiple state Medicaid plans to expand access.

Which Humana plans will accept Zynex devices under the new agreement with Humana (HUM)?

Zynex is participating in Humana Medicare-PPO, POS, Network PFFS and HMO plans under the agreement. According to the company, the participation also covers several state Medicaid plans and Integrated DSNP programs across multiple states.

How might the Humana (HUM) in-network status affect Zynex (ZYXIQ) patients' access to NexWave™?

In-network status should expand patient access to NexWave™ for Humana members across plan types and states. According to the company, Humana membership and included Medicaid plans will allow more members to obtain Zynex electrotherapy products through covered benefits.

Did Zynex disclose financial terms or expected revenue impact from the Humana (HUM) agreement?

No, Zynex did not disclose financial terms or projected revenue effects from the Humana agreement. According to the company, terms of the agreement were not disclosed, so any revenue or timing impact was not provided in the announcement.